Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
103 studies found for:    "Graves Disease"
Show Display Options
Rank Status Study
21 Unknown  Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
Condition: Graves' Disease
Intervention:
22 Active, not recruiting Early Levothyroxine Post Radioactive Iodine
Condition: Graves' Disease
Interventions: Drug: Levothyroxine;   Other: Placebo
23 Active, not recruiting Remission Induction and Sustenance in Graves' Disease 2
Conditions: Graves Disease;   Hyperthyroidism
Intervention: Other: Stop medication
24 Completed Rituximab in the Treatment of Graves' Disease
Conditions: Graves´ Disease;   Thyroid Associated Ophthalmopathy
Interventions: Drug: Methimazole;   Drug: Rituximab;   Biological: Immunization with various vaccines
25 Recruiting Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
Condition: Graves' Hyperthyroidism
Interventions: Dietary Supplement: Selenium;   Other: Placebo
26 Completed Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients
Condition: Graves' Disease
Intervention: Drug: Dexamethasone
27 Completed Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Conditions: Graves' Disease;   Thyroid Disease;   Hyperthyroidism
Intervention: Other: Decision Aid
28 Completed Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
Condition: Graves Disease
Intervention: Drug: Methimazole
29 Completed Post-Radioiodine Graves' Management: The PRAGMA-Study
Condition: Graves' Disease
Intervention:
30 Unknown  Role of the Microbiome in Graves' Orbitopathy
Condition: Graves' Disease
Intervention: Biological: LAB4
31 Unknown  Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
Condition: Graves' Disease
Intervention: Procedure: Radiotherapy
32 Completed Low Doses of Cholestyramine in the Treatment of Hyperthyroidism
Condition: Graves Disease
Interventions: Drug: Cholestyramine;   Drug: Placebo powder
33 Completed Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
Condition: Graves Disease (Basedow's Disease)
Interventions: Drug: the early prophylactic introduction of low dose of LT4 (50 µg/d) at 15 days post-ablation;   Drug: The initiation of LT4 as soon as the first biological signs of hypothyroidism.
34 Completed Subtotal Versus Total Thyroidectomy for Graves' Disease
Conditions: Thyroid;   Goiter
Interventions: Procedure: Bilateral subtotal thyroidectomy;   Procedure: Total thyroidectomy
35 Completed Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
Condition: Graves´ Disease
Interventions: Drug: Diclofenac;   Drug: Methimazole;   Drug: L-thyroxin;   Drug: Propranolol;   Drug: Metoprolol
36 Completed Low-dose Radioiodine Ablation in Graves' Disease
Condition: Thyroid Diseases
Intervention: Radiation: Radioiodine
37 Recruiting Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans
Conditions: Hyperthyroidism;   Tomography;   Emission-Computed;   Single-Photon
Intervention:
38 Completed rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter
Conditions: Benign Nontoxic and Toxic Goiter;   Graves' Disease
Intervention: Drug: Recombinant human thyrotropin (Thyrogen)
39 Completed Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy
Conditions: Graves' Disease;   Graves' Ophthalmopathy
Intervention:
40 Completed Antithyroid Drugs During Radioiodine Therapy
Conditions: Toxic Nodular Goitre;   Graves Disease
Intervention: Drug: Methimazole

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.